Regulation of mechanical stress-induced MMP-13 and ADAMTS-5 expression by RUNX-2 transcriptional factor in SW1353 chondrocyte-like cells

Osteoarthritis and Cartilage

Volumn 19, Issue 2, 2011, Pages 222-232

  Tetsunaga, T ^a   Nishida, K ^a   Furumatsu, T ^a   Naruse, K ^a   Hirohata, S ^a   Yoshida, A ^a   Saito, T ^a   Ozaki, T ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

ADAMTS; Aggrecanase; Chondrocyte; Mechanical stress; RUNX 2

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADAMTS 9 PROTEIN; AGGRECANASE 1; AGGRECANASE 2; COLLAGENASE 3; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ARTICLE; CARTILAGE CELL; CLINICAL ASSESSMENT; DOWN REGULATION; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MECHANICAL STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADAM PROTEINS; CELLS, CULTURED; CHONDROCYTES; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DOWN-REGULATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 13; P38 MITOGEN-ACTIVATED PROTEIN KINASES; POLYMERASE CHAIN REACTION; STRESS, MECHANICAL; UP-REGULATION;

EID: 79151483757     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2010.11.004     Document Type: Article

References (52)

1. Sah R.L., Kim Y.J., Doong J.Y., Grodzinsky A.J., Plaas A.H., Sandy J.D. Biosynthetic response of cartilage explants to dynamic compression. J Orthop Res 1989, 7:619-636.
2. Guilak F., Meyer B.C., Ratcliffe A., Mow V.C. The effects of matrix compression on proteoglycan metabolism in articular cartilage explants. Osteoarthritis Cartilage 1994, 2:91-101.
3. Curtin W.A., Reville W.J. Ultrastructural observations on fibril profiles in normal and degenerative human articular cartilage. Clin Orthop Relat Res 1995, 224-230.
4. Vincenti M.P., White L.A., Schroen D.J., Benbow U., Brinckerhoff C.E. Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability. Crit Rev Eukaryot Gene Expr 1996, 6:391-411.
5. Fosang A.J., Last K., Maciewicz R.A. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent. J Clin Invest 1996, 98:2292-2299.
6. Ohuchi E., Imai K., Fujii Y., Sato H., Seiki M., Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997, 272:2446-2451.
7. Selvamurugan N., Jefcoat S.C., Kwok S., Kowalewski R., Tamasi J.A., Partridge N.C. Overexpression of Runx2 directed by the matrix metalloproteinase-13 promoter containing the AP-1 and Runx/RD/Cbfa sites alters bone remodeling in vivo. J Cell Biochem 2006, 99:545-557.
8. Tortorella M.D., Burn T.C., Pratta M.A., Abbaszade I., Hollis J.M., Liu R., et al. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 1999, 284:1664-1666.
9. Abbaszade I., Liu R.Q., Yang F., Rosenfeld S.A., Ross O.H., Link J.R., et al. Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem 1999, 274:23443-23450.
10. Rodriguez-Manzaneque J.C., Westling J., Thai S.N., Luque A., Knauper V., Murphy G., et al. ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors. Biochem Biophys Res Commun 2002, 293:501-508.
11. Collins-Racie L.A., Flannery C.R., Zeng W., Corcoran C., Annis-Freeman B., Agostino M.J., et al. ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage. Matrix Biol 2004, 23:219-230.
12. Somerville R.P., Longpre J.M., Jungers K.A., Engle J.M., Ross M., Evanko S., et al. Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1. J Biol Chem 2003, 278:9503-9513.
13. Glasson S.S., Askew R., Sheppard B., Carito B., Blanchet T., Ma H.L., et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 2005, 434:644-648.
14. Stanton H., Rogerson F.M., East C.J., Golub S.B., Lawlor K.E., Meeker C.T., et al. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 2005, 434:648-652.
15. Glasson S.S., Askew R., Sheppard B., Carito B.A., Blanchet T., Ma H.L., et al. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthritis Rheum 2004, 50:2547-2558.
16. Majumdar M.K., Askew R., Schelling S., Stedman N., Blanchet T., Hopkins B., et al. Double-knockout of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis. Arthritis Rheum 2007, 56:3670-3674.
17. Kashiwagi M., Enghild J.J., Gendron C., Hughes C., Caterson B., Itoh Y., et al. Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing. J Biol Chem 2004, 279:10109-10119.
18. Naito S., Shiomi T., Okada A., Kimura T., Chijiiwa M., Fujita Y., et al. Expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic cartilage. Pathol Int 2007, 57:703-711.
19. Patwari P., Gao G., Lee J.H., Grodzinsky A.J., Sandy J.D. Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage. Osteoarthritis Cartilage 2005, 13:269-277.
20. Demircan K., Hirohata S., Nishida K., Hatipoglu O.F., Oohashi T., Yonezawa T., et al. ADAMTS-9 is synergistically induced by interleukin-1beta and tumor necrosis factor alpha in OUMS-27 chondrosarcoma cells and in human chondrocytes. Arthritis Rheum 2005, 52:1451-1460.
21. Fitzgerald J.B., Jin M., Dean D., Wood D.J., Zheng M.H., Grodzinsky A.J. Mechanical compression of cartilage explants induces multiple time-dependent gene expression patterns and involves intracellular calcium and cyclic AMP. J Biol Chem 2004, 279:19502-19511.
22. Agarwal S., Long P., Gassner R., Piesco N.P., Buckley M.J. Cyclic tensile strain suppresses catabolic effects of interleukin-1beta in fibrochondrocytes from the temporomandibular joint. Arthritis Rheum 2001, 44:608-617.
23. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
24. Kamekura S., Kawasaki Y., Hoshi K., Shimoaka T., Chikuda H., Maruyama Z., et al. Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis Rheum 2006, 54:2462-2470.
25. Wong M., Siegrist M., Goodwin K. Cyclic tensile strain and cyclic hydrostatic pressure differentially regulate expression of hypertrophic markers in primary chondrocytes. Bone 2003, 33:685-693.
26. Naruse K., Yamada T., Sokabe M. Involvement of SA channels in orienting response of cultured endothelial cells to cyclic stretch. Am J Physiol 1998, 274:H1532-H1538.
27. Hirano Y., Ishiguro N., Sokabe M., Takigawa M., Naruse K. Effects of tensile and compressive strains on response of a chondrocytic cell line embedded in type I collagen gel. J Biotechnol 2008, 133:245-252.
28. Tetsunaga T., Furumatsu T., Abe N., Nishida K., Naruse K., Ozaki T. Mechanical stretch stimulates integrin alphaVbeta3-mediated collagen expression in human anterior cruciate ligament cells. J Biomech 2009, 42:2097-2103.
29. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:e45.
30. Furumatsu T., Shukunami C., Amemiya-Kudo M., Shimano H., Ozaki T. Scleraxis and E47 cooperatively regulate the Sox9-dependent transcription. Int J Biochem Cell Biol 2010, 42:148-156.
31. Agarwal S., Deschner J., Long P., Verma A., Hofman C., Evans C.H., et al. Role of NF-kappaB transcription factors in antiinflammatory and proinflammatory actions of mechanical signals. Arthritis Rheum 2004, 50:3541-3548.
32. Holmvall K., Camper L., Johansson S., Kimura J.H., Lundgren-Akerlund E. Chondrocyte and chondrosarcoma cell integrins with affinity for collagen type II and their response to mechanical stress. Exp Cell Res 1995, 221:496-503.
33. Fujisawa T., Hattori T., Takahashi K., Kuboki T., Yamashita A., Takigawa M. Cyclic mechanical stress induces extracellular matrix degradation in cultured chondrocytes via gene expression of matrix metalloproteinases and interleukin-1. J Biochem 1999, 125:966-975.
34. Vandenburgh H.H., Solerssi R., Shansky J., Adams J.W., Henderson S.A., Lemaire J. Response of neonatal rat cardiomyocytes to repetitive mechanical stimulation in vitro. Ann N Y Acad Sci 1995, 752:19-29.
35. Kada K., Yasui K., Naruse K., Kamiya K., Kodama I., Toyama J. Orientation change of cardiocytes induced by cyclic stretch stimulation: time dependency and involvement of protein kinases. J Mol Cell Cardiol 1999, 31:247-259.
36. Song R.H., Tortorella M.D., Malfait A.M., Alston J.T., Yang Z., Arner E.C., et al. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. Arthritis Rheum 2007, 56:575-585.
37. Burrage P.S., Brinckerhoff C.E. Molecular targets in osteoarthritis: metalloproteinases and their inhibitors. Curr Drug Targets 2007, 8:293-303.
38. Thirunavukkarasu K., Pei Y., Moore T.L., Wang H., Yu X.P., Geiser A.G., et al. Regulation of the human ADAMTS-4 promoter by transcription factors and cytokines. Biochem Biophys Res Commun 2006, 345:197-204.
39. Thirunavukkarasu K., Pei Y., Wei T. Characterization of the human ADAMTS-5 (aggrecanase-2) gene promoter. Mol Biol Rep 2007, 34:225-231.
40. Tanne Y., Tanimoto K., Tanaka N., Ueki M., Lin Y.Y., Ohkuma S., et al. Expression and activity of Runx2 mediated by hyaluronan during chondrocyte differentiation. Arch Oral Biol 2008, 53:478-487.
41. Tortorella M.D., Malfait A.M., Deccico C., Arner E. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. Osteoarthritis Cartilage 2001, 9:539-552.
42. Yamanishi Y., Boyle D.L., Clark M., Maki R.A., Tortorella M.D., Arner E.C., et al. Expression and regulation of aggrecanase in arthritis: the role of TGF-beta. J Immunol 2002, 168:1405-1412.
43. Lee J.H., Fitzgerald J.B., Dimicco M.A., Grodzinsky A.J. Mechanical injury of cartilage explants causes specific time-dependent changes in chondrocyte gene expression. Arthritis Rheum 2005, 52:2386-2395.
44. Koshy P.J., Lundy C.J., Rowan A.D., Porter S., Edwards D.R., Hogan A., et al. The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction. Arthritis Rheum 2002, 46:961-967.
45. Bondeson J., Lauder S., Wainwright S., Amos N., Evans A., Hughes C., et al. Adenoviral gene transfer of the endogenous inhibitor IkappaBalpha into human osteoarthritis synovial fibroblasts demonstrates that several matrix metalloproteinases and aggrecanases are nuclear factor-kappaB-dependent. J Rheumatol 2007, 34:523-533.
46. Pei Y., Harvey A., Yu X.P., Chandrasekhar S., Thirunavukkarasu K. Differential regulation of cytokine-induced MMP-1 and MMP-13 expression by p38 kinase inhibitors in human chondrosarcoma cells: potential role of Runx2 in mediating p38 effects. Osteoarthritis Cartilage 2006, 14:749-758.
47. Kanno T., Takahashi T., Tsujisawa T., Ariyoshi W., Nishihara T. Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts. J Cell Biochem 2007, 101:1266-1277.
48. Liacini A., Sylvester J., Li W.Q., Huang W., Dehnade F., Ahmad M., et al. Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes. Exp Cell Res 2003, 288:208-217.
49. Li W.Q., Dehnade F., Zafarullah M. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway. J Immunol 2001, 166:3491-3498.
50. Liu J., Liu T., Zheng Y., Zhao Z., Liu Y., Cheng H., et al. Early responses of osteoblast-like cells to different mechanical signals through various signaling pathways. Biochem Biophys Res Commun 2006, 348:1167-1173.
51. Bevill S.L., Briant P.L., Levenston M.E., Andriacchi T.P. Central and peripheral region tibial plateau chondrocytes respond differently to in vitro dynamic compression. Osteoarthritis Cartilage 2009, 17:980-987.
52. Nicodemus G.D., Bryant S.J. Mechanical loading regimes affect the anabolic and catabolic activities by chondrocytes encapsulated in PEG hydrogels. Osteoarthritis Cartilage 2010, 18:126-137.